Navigation Links
Ultrasound With Elastography May Cut Down on Biopsies
Date:12/1/2009

Method improves diagnosis of benign versus cancerous lesions, researchers say

TUESDAY, Dec. 1 (HealthDay News) -- When used with ultrasound, elastography helps distinguish between cancerous and benign breast lesions, which reduces unnecessary biopsies, U.S. researchers have found.

About 80 percent of breast lesions that are biopsied turn out to be benign, according to the American Cancer Society.

"There's a lot of room to improve specificity with ultrasound, and elastography can help us do that," Dr. Stamatia V. Destounis, a diagnostic radiologist at Elizabeth Wende Breast Care in Rochester, N.Y., and the study's lead author, said in a news release from the Radiological Society of North America. "It's an easy way to eliminate needle biopsy for something that's probably benign."

Elastography measures the compressibility and mechanical properties of a lesion. Cancerous tumors tend to be stiffer than surrounding tissues or cysts, whereas benign lesions are more compressible.

"You can perform elastography at the same time as hand-held ultrasound and view the images on a split screen, with the two-dimensional ultrasound image on the left and the elastography image on the right," Destounis said.

As part of an ongoing study, 179 women underwent breast ultrasound and elastography. The researchers performed biopsies on the 134 solid lesions they detected. . They found that elastography correctly identified 98 percent of cancerous lesions and 82 percent of benign lesions, and they also determined that elastography was more accurate than ultrasound in gauging the size of the lesions.

The findings were to be presented Nov. 30 in Chicago at the annual meeting of the Radiological Society of North America.

In another study scheduled to be presented at the meeting, researchers found that high-frequency ultrasound with elastography can help distinguish between cancerous and benign skin lesions, which could improve the efficiency of skin cancer diagnosis.

Dr. Eliot L. Siegel, vice chairman of the radiology department at the University of Maryland School of Medicine in Baltimore and the study's lead author, said in the news release that "dermatologists tend to biopsy any lesions that seem visually suspicious for disease."

"Consequently," he said, "many benign lesions are needlessly biopsied in order to avoid the risk of missing a potentially deadly melanoma."

Siegel and his colleagues used ultra-high-frequency ultrasound to image cancerous and benign skin lesions on 40 people. They also calculated the elasticity ratio of the lesions and adjacent normal skin and used laboratory analysis to confirm their diagnoses. They found that benign lesions had high levels of elasticity, whereas cancerous lesions were much less elastic. The elasticity ratio of normal skin to adjacent lesions ranged from 0.04 to 0.3 for benign lesions to above 10.0 for cancerous lesions.

"The visualized portion of a skin lesion can be just the tip of the iceberg, and most dermatologists operate 'blindly' beyond what they can see on the surface," Siegel said. "High-frequency ultrasound provides almost microscopic resolution and enables us to get size, shape and extent of the lesion prior to biopsy."

More information

The U.S. National Cancer Institute has more about cancer diagnosis.



-- Robert Preidt



SOURCE: Radiological Society of North America, news release, Dec. 1, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Special ultrasound accurately identifies skin cancer
2. Special Ultrasound Accurately Identifies Skin Cancer
3. Simulated training for ultrasound-guided procedures improves safety without risk to patients
4. Philips Healthcare CEO Joins Focused Ultrasound Surgery Foundation Board of Directors
5. Dr. Marc Katz, Leading Podiatric Surgeon Adds High Powered Color Ultrasound To Cryosurgery Procedures and Treatments
6. Ultrasound can predict tumor burden and survival in melanoma patients
7. MEDISON Launches New Dedicated OB/GYN 3D/4D Ultrasound System, ACCUVIX V20 Prestige
8. Mindray DS USA Appoints Michael Thompson Vice President of U.S. Ultrasound Sales
9. ALOKA Announces New ProSound Alpha Series Ultrasound System
10. Tennis Elbow, Shin Splints and Carpal Tunnel Syndrome Could Be a Thing of the Past Due to New Efforts with Sports Musculoskeletal Ultrasound
11. AIUM announces management agreement with the International Society of Therapeutic Ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... With millions of Americans and ... that we all are aware of our options and are empowered with strength ... the launch of its newest edition of "Vision and Hearing" in USA Today, ...
(Date:2/24/2017)... Texas (PRWEB) , ... February 24, 2017 , ... Yisrayl ... that focuses on Bible Prophecy concerning this present generation. Yisrayl makes an astounding ... this current generation. He explains that the Bible details the current times so ...
(Date:2/24/2017)... Emeryville, CA (PRWEB) , ... February 24, 2017 ... ... Esparza for qualifying into the Senior International Elite division on February 12th. ... All Around divisions at the elite qualifier competition held in Las Vegas, Nevada. ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to the La Gorce Country Club in Miami Beach to host its Swirl: ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... , Feb. 23, 2017  Directors from Pharma To Market Pty ... have joined forces, resulting in the founding of Pharma To Market ... Pharma To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... of the Singapore based entity. Joelle brings ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
Breaking Medicine Technology: